FDA issues hold on much-debated Avandia study
Wednesday, July 21, 2010 - 12:42
in Health & Medicine
(AP) -- Federal health officials are barring new patients from enrolling in a safety study of GlaxoSmithKline's controversial diabetes pill Avandia, a week after a panel of experts ruled that the drug increases heart risks.